Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
layoffs
Biotech
Agios shedding 100 R&D roles ahead of hoped-for SCD approval
Agios has been shrinking its R&D headcount throughout 2026 as the commercial-stage company looks to shed more than 100 roles by year-end.
James Waldron
Nov 5, 2026 8:40am
Fierce Biotech Layoff Tracker 2026: Agios, Ultragenyx & more
Nov 5, 2026 4:00am
Ultragenyx shrinks workforce and axes assets to halve R&D spend
Nov 4, 2026 5:19am
Molecular Partners plots 44% staff cutback in radiotherapy pivot
Oct 30, 2026 3:18am
GSK plans ‘some limited impact’ to UK roles from restructuring
Oct 28, 2026 6:33am
The 2026 Biotech Graveyard
Oct 28, 2026 6:00am
